NZ518218A - Ligand activated transcriptional regulator proteins - Google Patents

Ligand activated transcriptional regulator proteins

Info

Publication number
NZ518218A
NZ518218A NZ518218A NZ51821800A NZ518218A NZ 518218 A NZ518218 A NZ 518218A NZ 518218 A NZ518218 A NZ 518218A NZ 51821800 A NZ51821800 A NZ 51821800A NZ 518218 A NZ518218 A NZ 518218A
Authority
NZ
New Zealand
Prior art keywords
fusion protein
vector
sequence
dna
nucleic acid
Prior art date
Application number
NZ518218A
Other languages
English (en)
Inventor
Carlos F Barbas
Michael Kadan
Roger Beerli
Original Assignee
Novartis Ag
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Scripps Research Inst filed Critical Novartis Ag
Publication of NZ518218A publication Critical patent/NZ518218A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ518218A 1999-10-25 2000-10-23 Ligand activated transcriptional regulator proteins NZ518218A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43304299A 1999-10-25 1999-10-25
US09/586,625 US7329728B1 (en) 1999-10-25 2000-06-02 Ligand activated transcriptional regulator proteins
PCT/EP2000/010430 WO2001030843A1 (en) 1999-10-25 2000-10-23 Ligand activated transcriptional regulator proteins

Publications (1)

Publication Number Publication Date
NZ518218A true NZ518218A (en) 2004-04-30

Family

ID=27029724

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ518218A NZ518218A (en) 1999-10-25 2000-10-23 Ligand activated transcriptional regulator proteins

Country Status (8)

Country Link
US (3) US7329728B1 (cg-RX-API-DMAC7.html)
EP (1) EP1226168A1 (cg-RX-API-DMAC7.html)
JP (2) JP2003512827A (cg-RX-API-DMAC7.html)
AU (1) AU775988B2 (cg-RX-API-DMAC7.html)
CA (1) CA2388535A1 (cg-RX-API-DMAC7.html)
IL (2) IL149142A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ518218A (cg-RX-API-DMAC7.html)
WO (1) WO2001030843A1 (cg-RX-API-DMAC7.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181360A1 (en) * 1999-05-28 2002-02-27 Sangamo Biosciences Inc. Molecular switches
US7329728B1 (en) * 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
AU2001226935B2 (en) * 2000-01-24 2006-06-22 Gendaq Limited Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
US7011972B2 (en) 2000-07-18 2006-03-14 The Scripps Research Institute Fusion polypeptide comprising two ligand binding domains
JP2004504029A (ja) * 2000-07-18 2004-02-12 ノバルティス　アクチエンゲゼルシャフト 単鎖、一量体、リガンド依存性ポリペプチドスイッチを用いる遺伝子発現の調節
US6919204B2 (en) 2000-09-29 2005-07-19 Sangamo Biosciences, Inc. Modulation of gene expression using localization domains
WO2002026960A2 (en) * 2000-09-29 2002-04-04 Sangamo Biosciences, Inc. Modulation of gene expression using localization domains
ES2409080T3 (es) * 2001-01-22 2013-06-24 Sangamo Biosciences Inc. Proteínas de unión con dedos de zinc modificadas
US7070993B2 (en) 2001-03-13 2006-07-04 Novartis Ag Lentiviral packaging constructs
DE60228082D1 (de) 2001-05-31 2008-09-18 Novartis Ag Nten und neue liganden und pharmazeutische zusammensetzungen
DK1531666T3 (da) 2002-05-29 2014-01-13 Regeneron Pharma Inducerbart eukaryot-ekspressionssystem
US8673589B2 (en) 2002-05-29 2014-03-18 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
EP1627046A4 (en) * 2003-05-06 2008-02-13 Scripps Research Inst BINDING MOLECULES WITH DOMAIN EXCHANGE, USE METHOD AND METHOD OF MANUFACTURE
US20070087346A1 (en) * 2003-10-24 2007-04-19 Gennaro Ciliberto Orthogonal gene switches
US7829528B2 (en) * 2004-09-14 2010-11-09 The Rockefeller University Compositions and methods for treating STAT-6 associated diseases or conditions
WO2009018576A1 (en) * 2007-08-02 2009-02-05 Biodesic Compositions and methods for analyte detection and quantitation
PL2441774T3 (pl) 2010-10-15 2019-05-31 Fund Centre De Regulacio Genòmica Peptydy zawierające motywy palców cynkowych i ich zastosowania
US8450107B1 (en) 2011-11-30 2013-05-28 The Broad Institute Inc. Nucleotide-specific recognition sequences for designer TAL effectors
US20130137173A1 (en) * 2011-11-30 2013-05-30 Feng Zhang Nucleotide-specific recognition sequences for designer tal effectors
US10801017B2 (en) 2011-11-30 2020-10-13 The Broad Institute, Inc. Nucleotide-specific recognition sequences for designer TAL effectors
TWI666222B (zh) * 2012-02-02 2019-07-21 陶氏農業科學公司 植物轉錄活化交互作用之模體（ｍｏｔｉｆ）及其用途
BR112014019431A8 (pt) 2012-02-07 2017-07-11 Global Bio Therapeutics Usa Inc Método compartimentalizado de distribuição de ácido nucleico e composições e usos desses
ES2987399T3 (es) * 2013-06-05 2024-11-14 Univ Duke Edición génica guiada por ARN y regulación génica
CN105813579B (zh) 2013-08-08 2019-05-07 全球生物疗法有限公司 用于微创手术过程的夹具装置和其应用
WO2017134137A1 (en) * 2016-02-05 2017-08-10 Polygene Ag Glucocorticoid-based gene regulation system
WO2017181152A2 (en) 2016-04-15 2017-10-19 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
SG11201808457PA (en) 2016-04-15 2018-10-30 Alpine Immune Sciences Inc Icos ligand variant immunomodulatory proteins and uses thereof
CA3032120A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd155 variant immunomodulatory proteins and uses thereof
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
WO2018022945A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd112 variant immunomodulatory proteins and uses thereof
AU2017345764A1 (en) 2016-10-20 2019-05-02 Alpine Immune Sciences, Inc. Secretable variant immunomodulatory proteins and engineered cell therapy
LT3596116T (lt) 2017-03-16 2023-11-10 Alpine Immune Sciences, Inc. Imunomoduliacinių baltymų pd-l1 variantai ir jų naudojimo būdai
CA3053812A1 (en) 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Pd-l2 variant immunomodulatory proteins and uses thereof
WO2018170026A2 (en) 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
EP3694870A1 (en) 2017-10-10 2020-08-19 Alpine Immune Sciences, Inc. Ctla-4 variant immunomodulatory proteins and uses thereof
MY203416A (en) 2017-10-18 2024-06-27 Alpine Immune Sciences Inc Variant icos ligand immunomodulatory proteins and related compositions and methods
JP7401432B2 (ja) * 2017-12-01 2023-12-19 エンコーデッド セラピューティクス， インコーポレイテッド 操作されたｄｎａ結合タンパク質
BR112020013236A2 (pt) 2018-01-03 2020-12-01 Alpine Immune Sciences, Inc. proteínas imunomoduladoras de múltiplos domínios e métodos de seu uso
WO2019241758A1 (en) 2018-06-15 2019-12-19 Alpine Immune Sciences, Inc. Pd-1 variant immunomodulatory proteins and uses thereof
SG11202102644XA (en) 2018-09-19 2021-04-29 Alpine Immune Sciences Inc Methods and uses of variant cd80 fusion proteins and related constructs
JP2022513113A (ja) 2018-11-26 2022-02-07 マサチューセッツ インスティテュート オブ テクノロジー 免疫寛容のための組成物および方法
US20220372106A1 (en) 2018-11-30 2022-11-24 Alpine Immune Sciences, Inc. Cd86 variant immunomodulatory proteins and uses thereof
AU2020257238A1 (en) 2019-04-17 2021-12-02 Alpine Immune Sciences, Inc. Methods and uses of variant ICOS Ligand (ICOSL) fusion proteins
CA3140902A1 (en) * 2019-05-28 2020-12-03 Octant, Inc. Transcriptional relay system
JP7704740B2 (ja) 2019-09-16 2025-07-08 アムジエン・インコーポレーテツド 薬物送達デバイスの外部滅菌の方法
US20230174612A1 (en) * 2020-04-09 2023-06-08 The Regents Of The University Of California Notch receptors with zinc finger-containing transcriptional effector
PE20230494A1 (es) 2020-05-08 2023-03-23 Alpine Immune Sciences Inc Proteinas inmunomoduladoras inhibidoras de april y baff y metodos de uso de las mismas
WO2022084748A1 (en) * 2020-10-23 2022-04-28 Spindle Biotech, Inc. Compositions and methods for rna synthesis
WO2023017494A1 (en) 2021-08-13 2023-02-16 Triovance Holding Llc A skin substitute composition and methods of producing and using the same
AU2024257450A1 (en) * 2023-04-17 2025-11-27 AskBio Inc. Regulatable controlled expression of a transgene in primates

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US147327A (en) * 1874-02-10 Improvement in weft-stop mechanisms for looms
US81614A (en) * 1868-09-01 Jacob erdle
US182698A (en) * 1876-09-26 Improvement in machines for canceling postage-stamps and postmarking letters
US540065A (en) * 1895-05-28 Andrew kriegee
US2996496A (en) 1956-06-22 1961-08-15 Central Pharmacal Company Calcium substitution products of dextran
US4394443A (en) 1980-12-18 1983-07-19 Yale University Method for cloning genes
US4446235A (en) 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
US4981784A (en) 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5317090A (en) 1987-12-16 1994-05-31 Institut Pasteur Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human hepatocellular carcinoma, and which is a retinoic acid receptor
US5217867A (en) * 1988-11-30 1993-06-08 The Salk Institute For Biological Studies Receptors: their identification, characterization, preparation and use
AU633045B2 (en) 1988-12-23 1993-01-21 Salk Institute For Biological Studies, The Receptor transcription-repression activity compositions and methods
US5198346A (en) 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US4990607A (en) 1989-03-14 1991-02-05 The Rockefeller University Alteration of gene expression in plants
US5140466A (en) * 1990-12-20 1992-08-18 Hughes Aircraft Company Optical multiplexer
DE69334150T2 (de) 1992-05-14 2008-03-13 Baylor College Of Medicine, Houston Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie
US6416998B1 (en) 1992-09-02 2002-07-09 Baylor College Of Medicine Plasmid encoding a modified steroid hormone
US5364791A (en) 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
GB9214857D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US6242568B1 (en) 1994-01-18 2001-06-05 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
CA2181548C (en) 1994-01-18 2009-11-03 Carlos F. Barbas, Iii Zinc finger protein derivatives and methods therefor
US20050084885A1 (en) 1994-01-18 2005-04-21 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US5789538A (en) 1995-02-03 1998-08-04 Massachusetts Institute Of Technology Zinc finger proteins with high affinity new DNA binding specificities
US6723531B2 (en) 1996-04-05 2004-04-20 The Salk Institute For Biological Studies Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
EP0935657B1 (en) 1996-10-29 2007-08-29 Baylor College Of Medicine Modified steroid hormone receptors
ATE466952T1 (de) 1998-03-02 2010-05-15 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US7329728B1 (en) 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
US7151201B2 (en) 2000-01-21 2006-12-19 The Scripps Research Institute Methods and compositions to modulate expression in plants
CA2396898A1 (en) 2000-01-21 2001-07-26 The Scripps Research Institute Methods and compositions to modulate expression in plants
JP2003531609A (ja) 2000-05-01 2003-10-28 ノバルティス アクチエンゲゼルシャフト 目に関する形質導入用ベクターおよび遺伝子治療を目的とするその用途
CA2414272A1 (en) 2000-07-10 2002-01-17 Novartis Ag Bifunctional molecules and vectors complexed therewith for targeted gene delivery
JP2004504029A (ja) 2000-07-18 2004-02-12 ノバルティス　アクチエンゲゼルシャフト 単鎖、一量体、リガンド依存性ポリペプチドスイッチを用いる遺伝子発現の調節
US7011972B2 (en) * 2000-07-18 2006-03-14 The Scripps Research Institute Fusion polypeptide comprising two ligand binding domains
ATE441712T1 (de) 2001-02-21 2009-09-15 Novartis Pharma Gmbh Die nukleotidsequenz ann bindende zink-finger domänen
US7067617B2 (en) 2001-02-21 2006-06-27 The Scripps Research Institute Zinc finger binding domains for nucleotide sequence ANN
DE60228082D1 (de) 2001-05-31 2008-09-18 Novartis Ag Nten und neue liganden und pharmazeutische zusammensetzungen
WO2003016496A2 (en) 2001-08-20 2003-02-27 The Scripps Research Institute Zinc finger binding domains for cnn
EP1516055A4 (en) 2002-01-24 2007-08-08 Scripps Research Inst FIBER OPERATING MODIFICATIONS FOR EFFICIENT TARGETS
WO2003066828A2 (en) 2002-02-07 2003-08-14 The Scripps Research Institute Zinc finger libraries
US20060211846A1 (en) * 2002-02-13 2006-09-21 Barbas Carlos F Iii Zinc finger binding domains for nucleotide sequence ANN
US20070020627A1 (en) 2002-06-11 2007-01-25 The Scripps Research Institute Artificial transcription factors
JP2008508221A (ja) * 2004-07-28 2008-03-21 グラクソ グループ リミテッド 消化器疾患の治療に有用なピペラジン誘導体
JP2009504156A (ja) * 2005-08-11 2009-02-05 ザ スクリップス リサーチ インスティテュート Ｃｎｎに対するジンクフィンガー結合ドメイン
CA2631422A1 (en) * 2005-11-28 2007-05-31 The Scripps Research Institute Zinc finger binding domains for tnn
US20070154989A1 (en) * 2006-01-03 2007-07-05 The Scripps Research Institute Zinc finger domains specifically binding agc
US8874746B1 (en) 2010-05-24 2014-10-28 Datacore Software Corporation Collaboration between discrete systems and a shared system to consolidate shared storage-related services

Also Published As

Publication number Publication date
US20080318839A1 (en) 2008-12-25
IL149142A (en) 2010-05-31
CA2388535A1 (en) 2001-05-03
IL149142A0 (en) 2002-11-10
US7442784B2 (en) 2008-10-28
US20030186841A1 (en) 2003-10-02
WO2001030843A9 (en) 2002-09-19
AU775988B2 (en) 2004-08-19
US7329728B1 (en) 2008-02-12
WO2001030843A1 (en) 2001-05-03
AU1143801A (en) 2001-05-08
JP2003512827A (ja) 2003-04-08
JP2009273463A (ja) 2009-11-26
EP1226168A1 (en) 2002-07-31

Similar Documents

Publication Publication Date Title
US7442784B2 (en) Ligand activated transcriptional regulator proteins
Wang et al. Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator
US7741110B2 (en) Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
JP3817739B2 (ja) キメラｄｎａ結合性タンパク質
US20090029468A1 (en) Zinc finger binding domains for cnn
US5866325A (en) Methods and materials relating to the functional domains of DNA binding proteins
JP2005500061A5 (cg-RX-API-DMAC7.html)
IL199916A (en) A polypeptide that binds zinc fingers that contains a nucleotide binding site
CA2543329A1 (en) Orthogonal gene switches
US7381813B2 (en) Nucleic acids encoding estrogen receptor ligand binding domain variants
Gavva et al. NAPP2, a peroxisomal membrane protein, is also a transcriptional corepressor
EP1303606B1 (en) Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
JP2004504029A5 (cg-RX-API-DMAC7.html)
JP2004500884A (ja) 遺伝子発現の調節方法及び手段
AU2001272544A1 (en) Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
AU2005234684B2 (en) Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
HK1115159A (en) Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: THE SCRIPPS RESEARCH INSTITUTE, US

Free format text: OLD OWNER(S): THE SCRIPPS RESEARCH INSTITUTE; NOVARTIS AG

RENW Renewal (renewal fees accepted)